ACI’s Recommendations to Expedite the Authorisation Process for Ingestible CBD Products
The ACI calls on the Food Standards Agency (FSA) and the Home Office to work together to resolve the outstanding issues stalling progress on British novel food applications. In a fresh bid to bring to a close the regulatory stalemate threatening an entire sector, the Association has produced a new white paper underlining the need […]
Press release: ACI response to Home Office announcement on legal framework for CBD products
The Association for the Cannabinoid Industry (ACI) has published a response to today’s Home Office announcement accepting expert recommendations to create the UK’s first legal framework for consumer CBD products that contain controlled cannabinoids. The government proposals follow an ACI campaign launched in August urging the Home Office to update the law, which risked stifling […]
Position statement: ACI calls for greater clarity on process underpinning FSA consumer guidance for CBD
The Association for the Cannabinoid Industry is seeking clarification on the process behind the Food Standards Agency’s recently updated consumer advice for acceptable daily intake for CBD. This guidance now sets the provisional ADI at 10mg a day, with the departure from the previous recommendation of 70mg a day causing substantial anxiety among brands, manufacturers, […]
Statement: ACI Responds to Updated CBD Consumer Advice from Food Standards Agency (FSA)
London, 12 October 2023 – The Association for the Cannabinoid Industry (ACI) acknowledges the updated consumer advice from the Food Standards Agency (FSA) recommending a daily limit of 10mg of Cannabidiol (CBD) for healthy adults. As an organisation committed to the responsible and safe use of CBD products, we understand the importance of evidence-based recommendations […]
ACI, CMC and Chem ID Join Forces to Ensure Authenticity, Validation, and Quality Assurance for Cannabis Products
In a groundbreaking partnership, the Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) have teamed up with Chem ID to revolutionize the UK’s legal cannabis industry’s commitment to product authenticity, validation, and quality assurance. The Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) are delighted […]
Statement: ACI novel foods applications validated by FSA
The Association for the Cannabinoid Industry’s (ACI) novel foods applications (RP126 and RP127) have been validated by the Food Standards Agency (FSA). The ACI has received formal notification from the FSA that both its applications for the authorisation of CBD isolate and distillate ‘fall within the scope of the novel foods regime’ as set out […]
ACI submits complete toxicological package to the Food Standards Agency (FSA)
We are thrilled to announce that on Friday 4th November 2022, the Association for the Cannabinoid Industry submitted our complete toxicological package to the Food Standards Agency (FSA) to support the Novel Food Applications of our members. Their applications account for 33% of the public list and we look forward to them achieving validation, and […]
Prof Christopher Hodges appointed to Chair Government’s Regulatory Horizons Council
Prof Christopher Hodges, who recently completed a strategic review of the UK legal cannabinoid industry for the CMC/ACI, has today been appointed Chair of the Regulatory Horizons Council by the Business Secretary. Steve Moore, the CMC/ACI co-founder who commissioned Hodges to lead our review has welcomed this news as a huge opportunity for the sector […]
FSA CBD List Update Statement
This morning the FSA updated their CBD list. In an associated statement Paul Tossell the FSA’s Team Leader, Novel Foods said “The list has grown to nearly 12k and is now regarded as closed. Further additions will only be by exception and judged on a case-by-case basis. Local authorities have been updated on the status […]
ACI co-launches in-depth review of the UK’s cannabinoid industry with 20 key recommendations
In February this year following a series of meetings with Ministers, advisers and senior officials in Whitehall the Centre of Medicinal Cannabis and the Association for the Cannabinoid Industry commissioned Oxford University’s Professor Christopher Hodges to oversee a comprehensive review of the UK legal cannabinoid industry with a particular regard to how public policy and […]
